Keyword Analysis & Research: nccn prostate cancer
Keyword Research: People who searched nccn prostate cancer also searched
Search Results related to nccn prostate cancer on Search Engine
-
Treatment by Cancer Type - NCCN
https://www.nccn.org/guidelines/category_1
WebNCCN Guidelines. Treatment by Cancer Type. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) are posted with the latest update date and version number. Acute Lymphoblastic Leukemia. Version: 4.2023. Acute Myeloid Leukemia. Version: 1.2024. Ampullary Adenocarcinoma. Version: 1.2024. Anal Carcinoma. Version: 1.2024.
DA: 31 PA: 2 MOZ Rank: 4
-
NCCN Guidelines
https://www.nccn.org/guidelines/nccn-guidelines
WebProstate Cancer Early Detection. Adult Cancer PainAntiemesisCancer-Associated Venous Thromboembolic DiseaseCancer-Related Fatigue. Distress ManagementHematopoietic Cell TransplantationHematopoietic Growth FactorsManagement …
DA: 54 PA: 20 MOZ Rank: 38
-
Prostate Cancer, Version 4.2023, NCCN Clinical Practice …
https://jnccn.org/view/journals/jnccn/21/10/article-p1067.xml
WebThe NCCN Guidelines for Prostate Cancer provide a framework on which to base decisions regarding the workup of patients with prostate cancer, risk stratification and management of localized disease, post-treatment monitoring, and treatment of …
DA: 41 PA: 95 MOZ Rank: 27
-
Prostate Cancer, Version 4.2023, NCCN Clinical Practice
https://pubmed.ncbi.nlm.nih.gov/37856213/
WebThe NCCN Guidelines for Prostate Cancer provide a framework on which to base decisions regarding the workup of patients with prostate cancer, risk stratification and management of localized disease, post-treatment monitoring, and treatment of …
DA: 25 PA: 71 MOZ Rank: 69
-
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023
https://pubmed.ncbi.nlm.nih.gov/36509074/
WebThe NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, recurrent, and metastatic disease. The NCCN Prostate Cancer Panel meets annually to reevaluate and update their recommendations based ….
DA: 50 PA: 95 MOZ Rank: 30
-
NCCN Clinical Practice Guidelines in Oncology (NCCN …
https://www2.tri-kobe.org/nccn/guideline/urological/english/prostate.pdf
WebUpdates in Version 3.2019 of the NCCN Guidelines for Prostate Cancer from Version 2.2019 include: PROS-14 • Systemic therapy for castration-naive disease: Added apalutamide as a (category 1) option for M1 prostate cancer. Added enzalutamide as a (category 1) option for M1 prostate cancer. PROS-15
DA: 11 PA: 48 MOZ Rank: 6
-
Prostate Cancer, Version 2.2019, NCCN Clinical Practice …
https://jnccn.org/view/journals/jnccn/17/5/article-p479.xml
WebThe NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis, risk stratification and workup, treatment options for localized disease, and management of recurrent and advanced disease for clinicians who treat patients with prostate cancer.
DA: 16 PA: 31 MOZ Rank: 63
-
Prostate Cancer, Version 4
https://jnccn.org/downloadpdf/view/journals/jnccn/21/10/article-p1067.pdf
WebThe NCCN Guidelines for Prostate Cancer provide a framework on whichtobasedecisionsregardingtheworkupofpatientswithprostate cancer, risk stratification and management of localized disease, post-treatment monitoring, and treatment of recurrence and advanced disease.
DA: 32 PA: 29 MOZ Rank: 15
-
NCCN Guidelines for Patients: Advanced-Stage Prostate Cancer
https://www.nccn.org/patients/guidelines/content/PDF/prostate-advanced-patient.pdf
WebThese NCCN Guidelines for Patients are based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Prostate Cancer, Version 4.2023 — September 7, 2023. View the NCCN Guidelines for Patients free online. NCCN.org/patientguidelines. Find an NCCN Cancer Center near you. NCCN.org/cancercenters. Connect with us.
DA: 53 PA: 65 MOZ Rank: 54
-
Prostate Cancer, Version 2.2019, NCCN Clinical Practice
https://pubmed.ncbi.nlm.nih.gov/31085757/
WebMay 1, 2019 · Abstract. The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis, risk stratification and workup, treatment options for localized disease, and management of recurrent and advanced disease for clinicians who treat patients with prostate cancer.
DA: 54 PA: 50 MOZ Rank: 57